PCV13 Pediatric Routine Schedule Completion and Adherence Before and During the COVID-19 Pandemic in the United States

INTRODUCTION: A 13-valent pneumococcal conjugate vaccine (PCV13) was licensed to protect against emerging Streptococcus pneumoniae serotypes. Healthcare services, including routine childhood immunizations, were disrupted as a result of coronavirus disease 2019 (COVID-19). This study compared PCV13 r...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Liping, Nguyen, Jennifer L., Alfred, Tamuno, Perdrizet, Johnna, Cane, Alejandro, Arguedas, Adriano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552144/
https://www.ncbi.nlm.nih.gov/pubmed/36219342
http://dx.doi.org/10.1007/s40121-022-00699-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552144/
https://www.ncbi.nlm.nih.gov/pubmed/36219342
http://dx.doi.org/10.1007/s40121-022-00699-5

Ejemplares similares